Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of infliximab in patients with autoimmune hepatitis.

Hepatology (Baltimore, Md.)·2024
Same author

N-Acetylcysteine for the Management of Non-Acetaminophen Drug-Induced Liver Injury in Adults: A Systematic Review.

Frontiers in pharmacology·2022
Same author

A retrospective analysis of the duration of mechanical ventilation in Scandinavian paediatric heart centres.

Acta paediatrica (Oslo, Norway : 1992)·2022
Same author

Clinical characteristics of antiepileptic-induced liver injury in patients from the DILIN prospective study.

Journal of hepatology·2021
Same author

Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis.

Liver international : official journal of the International Association for the Study of the Liver·2021
Same author

Becoming an Expert by Experience: Benefits and Challenges of Educating Mental Health Nursing Students.

Issues in mental health nursing·2021

Related Experiment Video

Updated: Jul 6, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Immunoglobulin G4-associated cholangitis.

Einar Björnsson1

  • 1Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden. einar.bjornsson@medic.gu.se

Current Opinion in Gastroenterology
|April 15, 2008
PubMed
Summary
This summary is machine-generated.

Recent studies highlight that Immunoglobulin G4-associated cholangitis (IAC) involves T helper 2 cell overproduction and upregulated cytokines. Diagnostic immunoglobulin G4 immunostaining is crucial, and multiple level measurements aid diagnosis, with relapses common despite initial steroid response.

More Related Videos

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
07:44

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

Related Experiment Videos

Last Updated: Jul 6, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
07:44

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

Area of Science:

  • Gastroenterology
  • Immunology
  • Pathology

Background:

  • Immunoglobulin G4-associated cholangitis (IAC) is a distinct clinical entity.
  • Characterized by plasma cell infiltration bearing immunoglobulin G4 (IgG4) in bile ducts and other tissues.

Purpose of the Study:

  • To review recent studies (last 2 years) advancing the understanding of IAC.
  • Focus on immune mechanisms, histology, clinical/radiological features, and medical therapy.

Main Methods:

  • Review of recent scientific literature on IAC.
  • Analysis of immune mechanisms, liver histology, clinical presentations, and therapeutic responses.

Main Results:

  • IAC involves T helper 2 cell overproduction and upregulated regulatory cytokines (IL-10, TGF-β).
  • IgG4 immunostaining is vital for diagnosis, especially with normal IgG4 levels.
  • Multiple IgG4 level measurements are important, detecting elevated levels missed on initial testing.
  • Steroid therapy shows initial efficacy, but relapses are frequent.
  • Elevated IgG4 levels are observed in a significant portion of primary sclerosing cholangitis patients.

Conclusions:

  • IAC pathogenesis involves specific immune cell and cytokine profiles.
  • Diagnostic strategies for IAC benefit from IgG4 immunostaining and serial IgG4 level monitoring.
  • While steroids offer initial relief, long-term management of IAC requires further investigation due to common relapses.